 Pharmacoepidemiology
"Pharmacoepidemiology" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The science concerned with the benefit and risk of drugs used in populations and the analysis of the outcomes of drug therapies. Pharmacoepidemiologic data come from both clinical trials and epidemiological studies with emphasis on methods for the detection and evaluation of drug-related adverse effects, assessment of risk vs benefit ratios in drug therapy, patterns of drug utilization, the cost-effectiveness of specific drugs, methodology of postmarketing surveillance, and the relation between pharmacoepidemiology and the formulation and interpretation of regulatory guidelines. (Pharmacoepidemiol Drug Saf 1992;1(1); J Pharmacoepidemiol 1990;1(1))
| Descriptor ID |
D017891
|
| MeSH Number(s) |
H01.158.703.045 H02.403.720.500.650 H02.628.413
|
| Concept/Terms |
Pharmacoepidemiology- Pharmacoepidemiology
- Pharmaceutical Epidemiology
- Epidemiologies, Pharmaceutical
- Pharmaceutical Epidemiologies
- Epidemiology, Pharmaceutical
|
Below are MeSH descriptors whose meaning is more general than "Pharmacoepidemiology".
Below are MeSH descriptors whose meaning is more specific than "Pharmacoepidemiology".
This graph shows the total number of publications written about "Pharmacoepidemiology" by people in this website by year, and whether "Pharmacoepidemiology" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 0 | 4 | 4 | | 2015 | 1 | 2 | 3 | | 2016 | 1 | 1 | 2 | | 2018 | 1 | 0 | 1 | | 2019 | 0 | 2 | 2 | | 2021 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Pharmacoepidemiology" by people in Profiles.
-
Xu S, Clarke CL, Newcomer SR, Daley MF, Glanz JM. Sensitivity analyses of unmeasured and partially-measured confounders using multiple imputation in a vaccine safety study. Pharmacoepidemiol Drug Saf. 2021 09; 30(9):1200-1213.
-
Black JC, Forber A, Severtson SG, Rockhill K, May KP, Amioka E, Schwarz J, Iwanicki J, Dart RC. Drug product dispensing and estimates of use in a general population survey as a signal detection problem. Pharmacoepidemiol Drug Saf. 2021 08; 30(8):1132-1139.
-
Kiser TH, Reynolds PM, Moss M, Burnham EL, Ho PM, Vandivier RW. Impact of Macrolide Antibiotics on Hospital Readmissions and Other Clinically Important Outcomes in Critically Ill Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Propensity Score-Matched Cohort Study. Pharmacotherapy. 2019 03; 39(3):242-252.
-
Baker C, Feinstein JA, Ma X, Bolen S, Dawson NV, Golchin N, Horace A, Kleinman LC, Meropol SB, Pestana Knight EM, Winterstein AG, Bakaki PM. Variation of the prevalence of pediatric polypharmacy: A scoping review. Pharmacoepidemiol Drug Saf. 2019 03; 28(3):275-287.
-
Green JL, Anderson V, Dart RC, Heard K. Medication history assessment in research: A randomized controlled trial comparing tablet-based (eMedHAT) versus structured interview (MedHAT). Pharmacoepidemiol Drug Saf. 2018 Dec; 27(12):1356-1360.
-
Dai D, Feinstein JA, Morrison W, Zuppa AF, Feudtner C. Epidemiology of Polypharmacy and Potential Drug-Drug Interactions Among Pediatric Patients in ICUs of U.S. Children's Hospitals. Pediatr Crit Care Med. 2016 05; 17(5):e218-28.
-
Lasky T, Artaman A, Czaja AS, Maruti SS, Osokogu OU, Verhamme KM, Sobel RE. Current needs in pediatric pharmacoepidemiology. Pharmacoepidemiol Drug Saf. 2016 06; 25(6):738-42.
-
Zhang F, Mamtani R, Scott FI, Goldberg DS, Haynes K, Lewis JD. Increasing use of prescription drugs in the United Kingdom. Pharmacoepidemiol Drug Saf. 2016 06; 25(6):628-36.
-
Radawski C, Morrato E, Hornbuckle K, Bahri P, Smith M, Juhaeri J, Mol P, Levitan B, Huang HY, Coplan P, Li H. Benefit-Risk Assessment, Communication, and Evaluation (BRACE) throughout the life cycle of therapeutic products: overall perspective and role of the pharmacoepidemiologist. Pharmacoepidemiol Drug Saf. 2015 Dec; 24(12):1233-40.
-
Davis RL, Gallagher MA, Asgari MM, Eide MJ, Margolis DJ, Macy E, Burmester JK, Selvam N, Boscarino JA, Cromwell LF, Feigelson HS, Kuntz JL, Pawloski PA, Penfold RB, Raebel MA, Sridhar G, Wu A, La Grenade LA, Pacanowski MA, Pinheiro SP. Identification of Stevens-Johnson syndrome and toxic epidermal necrolysis in electronic health record databases. Pharmacoepidemiol Drug Saf. 2015 Jul; 24(7):684-92.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|